Adeka (4401) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
10 Mar, 2026Organizational transformation and strategic focus
Reorganized into four divisions, including a dedicated Semiconductor Materials Division, to enhance specialization and sales expansion.
Integrated sales, research, and planning functions to better respond to market needs and drive growth.
Aims to increase capital efficiency and earning power, targeting net sales of ¥500 billion.
Vision and financial targets
Seeks to support ICT-driven societal changes by creating new value with advanced materials.
Projects net sales to grow from ¥32.5 billion in FY2023 to over ¥110 billion by FY2030.
Operating profit expected to rise from ¥9.0 billion to over ¥22 billion by FY2030.
Plans active capital and R&D investment to sustain growth.
Product focus and market expansion
Anticipates continued growth in high-k materials for advanced memory and logic ICs.
Expanding sales of materials for EUV lithography and back-end process applications.
Investing in Taiwan and South Korea, and restructuring domestic plants to support growth.
Latest events from Adeka
- Profit and sales rose, led by Life Science, with stable outlook and higher dividend forecast.4401
Q1 202610 Mar 2026 - Life Science strength drove profit growth, offsetting Chemicals and Food Products weakness.4401
Q2 202610 Mar 2026 - Profits and sales grew, led by Chemicals and Food Products, with raised outlook and Life Science loss.4401
Q1 202510 Mar 2026 - 3Q FY2024 saw higher sales and profits, driven by Chemicals and global expansion.4401
Q3 202510 Mar 2026 - Strong 1H FY2024 results and Chemicals growth led to higher guidance and dividend forecasts.4401
Q2 202510 Mar 2026 - Record sales and profit growth driven by Chemicals, with continued expansion and higher dividends forecast.4401
Q4 202510 Mar 2026 - Profit rose on strong Life Science and Environmental Materials, offsetting Chemicals weakness.4401
Q3 202610 Mar 2026